Evidence map›Paper›PMID 24752199›Full record

ReviewCurrent opinion in supportive and palliative care2014

Descending pain modulation and chronification of pain.

Michael H Ossipov, Kozo Morimura, Frank Porreca

Open access · greenAbstract readReview
In one paragraph

Review in Current opinion in supportive and palliative care, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 399 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
399citing papers in PubMed, 1 pooled it
18.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

399 citing papers in PubMed, 1 synthesis or guideline pooled it, 760 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Effect ofNutrients · 2026
    Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Dopamine transporter gene (Pain reports · 2026
    Article
  19. Article
  20. Article

339 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Michael H OssipovDepartment of Pharmacology, Arizona Health Sciences Center, University of Arizona, Tucson, Arizona, USA.
Kozo Morimura
Frank Porreca
University of Arizona · US

Funding

Brain reward circuits and relief of ongoing painR01DA034975 · NIDA · UNIVERSITY OF ARIZONA · PI PORRECA, FRANK · 2013 to 2017
$2.8M
Mechanisms of Spontaneous Neuropathic PainR01NS066958 · NINDS · UNIVERSITY OF ARIZONA · PI PORRECA, FRANK · 2010 to 2014
$1.6M
NIDA NIH HHS DA034975NIDA NIH HHS R01 DA034975NINDS NIH HHS NS066958NINDS NIH HHS R01 NS066958
6 · The paper itself

Abstract

purpose of reviewChronic pain is an important public health problem that negatively impacts quality of life of affected individuals and exacts an enormous socio-economic cost. Currently available therapeutics provide inadequate management of pain in many patients. Acute pain states generally resolve in most patients. However, for reasons that are poorly understood, in some individuals, acute pain can transform to a chronic state. Our understanding of the risk factors that underlie the development of chronic pain is limited. Recent studies have suggested an important contribution of dysfunction in descending pain modulatory circuits to pain 'chronification'. Human studies provide insights into possible endogenous and exogenous factors that may promote the conversion of pain into a chronic condition. RECENT

findingsDescending pain modulatory systems have been studied and characterized in animal models. Human brain imaging techniques, deep brain stimulation and the mechanisms of action of drugs that are effective in the treatment of pain confirm the clinical relevance of top-down pain modulatory circuits. Growing evidence supports the concept that chronic pain is associated with a dysregulation in descending pain modulation. Disruption of the balance of descending modulatory circuits to favour facilitation may promote and maintain chronic pain. Recent findings suggest that diminished descending inhibition is likely to be an important element in determining whether pain may become chronic. This view is consistent with the clinical success of drugs that enhance spinal noradrenergic activity, such as serotonin/norepinephrine reuptake inhibitors (SNRIs), in the treatment of chronic pain states. Consistent with this concept, a robust descending inhibitory system may be normally engaged to protect against the development of chronic pain. Imaging studies show that higher cortical and subcortical centres that govern emotional, motivational and cognitive processes communicate directly with descending pain modulatory circuits providing a mechanistic basis to explain how exogenous factors can influence the expression of chronic pain in a susceptible individual. SUMMARY: Preclinical studies coupled with clinical pharmacologic and neuroimaging investigations have advanced our understanding of brain circuits that modulate pain. Descending pain facilitatory and inhibitory circuits arising ultimately in the brainstem provide mechanisms that can be engaged to promote or protect against pain 'chronification'. These systems interact with higher centres, thus providing a means through which exogenous factors can influence the risk of pain chronification. A greater understanding of the role of descending pain modulation can lead to novel therapeutic directions aimed at normalizing aberrant processes that can lead to chronic pain.

Indexed as

Acute DiseaseAnimalsBrainChronic PainEmotionsHumansMotivationNociceptorsPainQuality of LifeRisk FactorsSerotoninSpineSerotonin

Identifiers

PMID24752199
PMCPMC4301419
OpenAlexW2399492758

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.